ST.27-legal status data

The legal status information displayed below is based on WIPO Standard ST.27 and of a purely informative nature. Binding information on the status of the IP right is only available in DPMAregister (Show details).

DE file number: 60 2007 059 066.3, EP file number: 13 17 5987.0 (Designation/title: Verfahren zur Behandlung von Entzündungs- und Autoimmunerkrankungen mit Natalizumab)

Tabular representation
Current state: Not active, Current state: Termination likely/termination

Key event history
No. Key Event Code Key Event Name Event Date Effective Date Effective Date sorted ascending Publication Date To Stage
1 Q10 Document published Dec 25, 2013Dec 25, 2013 Filing
2 Q10 Document published Feb 6, 2014Feb 6, 2014Feb 6, 2014 Filing
3 Q10 Document published Aug 14, 2019Aug 14, 2019 Examination
4 Q10 Document published Sep 5, 2019Sep 5, 2019Sep 5, 2019 Examination
5 E10 Pre-grant review requested May 14, 2020May 14, 2020Jul 2, 2020 Pre-grant challenge
6 B10 Application discontinued Dec 7, 2022Dec 7, 2022Apr 6, 2023 Termination likely/termination
Detailed event history
No. Detailed Event Code Detailed Event Name Event Date Effective Date Effective Date sorted ascending Publication Date To Stage
1 Q12 Application published Dec 25, 2013Dec 25, 2013 Filing
2 Q10 Document published Feb 6, 2014Feb 6, 2014Feb 6, 2014 Filing
3 P22 Classification modified Mar 6, 2018Mar 6, 2018 Filing
4 Q10 Document published Aug 14, 2019Aug 14, 2019 Examination
5 Q10 Document published Sep 5, 2019Sep 5, 2019Sep 5, 2019 Examination
6 E11 Pre-grant opposition filed May 14, 2020May 14, 2020Jul 2, 2020 Pre-grant challenge
7 B17 Application discontinued following pre-grant review Dec 7, 2022Dec 7, 2022Apr 6, 2023 Termination likely/termination

Graphical representation

Below you will see a simplified graphical representation of the legal status information, which is based on WIPO Standard ST.27 using the "Overall Patent/SPC Prosecution Model" defined therein.

Graphical representation of the ST.27 legal status data